Skip to Main Content

Tezepelumab COPD Exacerbation Study (COURSE)


Asthma | Diseases of the Lung

Phase IIA

What is the purpose of this trial?

To evaluate the effect of tezepelumab as compared with placebo on COPD exacerbations in subjects with moderate to very severe COPD

  • Trial with
    Astra Zeneca
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC